日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Antibody dependent cellular cytotoxicity-inducing anti-EGFR antibodies as effective therapeutic option for cutaneous melanoma resistant to BRAF inhibitors

抗体依赖性细胞毒性诱导抗 EGFR 抗体是治疗对 BRAF 抑制剂有耐药性的皮肤黑色素瘤的有效治疗选择

Elena Muraro #, Barbara Montico #, Benedict Lum, Francesca Colizzi, Giorgio Giurato, Annamaria Salvati, Roberto Guerrieri, Aurora Rizzo, Elisa Comaro, Vincenzo Canzonieri, Andrea Anichini, Michele Del Vecchio, Roberta Mortarini, Massimo Milione, Alessandro Weisz, Maria Antonietta Pizzichetta, Fiona

Local High-Dose Radiotherapy Induces Systemic Immunomodulating Effects of Potential Therapeutic Relevance in Oligometastatic Breast Cancer

局部高剂量放射治疗可诱导全身免疫调节作用,对寡转移性乳腺癌具有潜在的治疗意义

Muraro, Elena; Furlan, Carlo; Avanzo, Michele; Martorelli, Debora; Comaro, Elisa; Rizzo, Aurora; Fae', Damiana A; Berretta, Massimiliano; Militello, Loredana; Del Conte, Alessandro; Spazzapan, Simon; Dolcetti, Riccardo; Trovo', Marco

Exploiting a new strategy to induce immunogenic cell death to improve dendritic cell-based vaccines for lymphoma immunotherapy

利用诱导免疫原性细胞死亡的新策略来改善基于树突状细胞的淋巴瘤免疫治疗疫苗

B Montico, C Lapenta, M Ravo, D Martorelli, E Muraro, B Zeng, E Comaro, M Spada, S Donati, S M Santini, R Tarallo, G Giurato, F Rizzo, A Weisz, F Belardelli, R Dolcetti, J Dal Col

Improved Natural Killer cell activity and retained anti-tumor CD8(+) T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy

增强的自然杀伤细胞活性和保留的抗肿瘤CD8(+) T细胞反应有助于诱导接受新辅助化疗的HER2阳性乳腺癌患者达到病理完全缓解。

Muraro, E; Comaro, E; Talamini, R; Turchet, E; Miolo, G; Scalone, S; Militello, L; Lombardi, D; Spazzapan, S; Perin, T; Massarut, S; Crivellari, D; Dolcetti, Riccardo; Martorelli, D